Kachhela Medex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 9 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 M
as on 22-12-2024
- Revenue -21.01%
(FY 2023)
- Profit -6.65%
(FY 2023)
- Ebitda -60.38%
(FY 2023)
- Net Worth 53.78%
(FY 2023)
- Total Assets 31.34%
(FY 2023)
About Kachhela Medex
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.00 M.
Mamta Gangwani and Anilkumar Gangwani serve as directors at the Company.
- CIN/LLPIN
U52100MH2015PTC271064
- Company No.
271064
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kachhela Medex Private Limited offer?
Kachhela Medex Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Surgical & ICU Equipments, Pulse Oximeter, Glucometer & POCT Devices, Flavours & Aromatics, Food Enzymes.
Who are the key members and board of directors at Kachhela Medex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamta Gangwani  | Director | 16-Dec-2015 | Current |
| Anilkumar Gangwani | Director | 16-Dec-2015 | Current |
Financial Performance of Kachhela Medex.
Kachhela Medex Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.01% decrease. The company also saw a slight decrease in profitability, with a 6.65% decrease in profit. The company's net worth Soared by an impressive increase of 53.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kachhela Medex?
Unlock access to Kachhela Medex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 29 Dec 2022 | ₹8.00 M | Open |
How Many Employees Work at Kachhela Medex?
Unlock and access historical data on people associated with Kachhela Medex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kachhela Medex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kachhela Medex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
